Icici Prudential Asset Management CO LTD Biogen Inc. Transaction History

Icici Prudential Asset Management CO LTD

$883 Million
Q4 2024

A detailed history of Icici Prudential Asset Management CO LTD transactions in Biogen Inc. stock. As of the latest transaction made, Icici Prudential Asset Management CO LTD holds 28,249 shares of BIIB stock, worth $4.03 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

28,249

Previous 30,368 6.98%

Holding current value

$4.03 Million

Previous $5.89 Million 26.62%

% of portfolio

0.49%

Previous 0.64%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$146.47 - $191.55 $310,369 - $405,894	-2,119 Reduced 6.98%	28,249 $4.32 Million
Q3 2024 Nov 05, 2024	SELL	$189.07 - $236.8 $1.8 Million - $2.26 Million	-9,529 Reduced 23.88%	30,368 $5.89 Million
Q2 2024 Jul 22, 2024	SELL	$190.52 - $236.72 $237,768 - $295,426	-1,248 Reduced 3.03%	39,897 $9.25 Million
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $1.09 Million - $1.38 Million	5,156 Added 14.33%	41,145 $8.87 Million
Q4 2023 Jan 19, 2024	BUY	$222.59 - $267.94 $1.04 Million - $1.26 Million	4,693 Added 15.0%	35,989 $9.31 Million
Q3 2023 Nov 02, 2023	BUY	$253.3 - $285.89 $715,319 - $807,353	2,824 Added 9.92%	31,296 $8.04 Million
Q2 2023 Jul 20, 2023	SELL	$275.25 - $318.06 $795,747 - $919,511	-2,891 Reduced 9.22%	28,472 $8.11 Million
Q1 2023 May 04, 2023	BUY	$256.56 - $292.34 $2.1 Million - $2.39 Million	8,177 Added 35.27%	31,363 $8.72 Million
Q4 2022 Feb 07, 2023	SELL	$252.44 - $306.72 $3.29 Million - $3.99 Million	-13,021 Reduced 35.96%	23,186 $6.42 Million
Q3 2022 Oct 28, 2022	BUY	$194.69 - $268.46 $745,078 - $1.03 Million	3,827 Added 11.82%	36,207 $9.67 Million
Q2 2022 Aug 05, 2022	BUY	$187.54 - $223.02 $2,625 - $3,122	14 Added 0.04%	32,380 $6.65 Million
Q1 2022 May 09, 2022	BUY	$193.77 - $244.14 $592,936 - $747,068	3,060 Added 10.44%	32,366 $6.83 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $2.05 Million - $2.64 Million	9,162 Added 45.48%	29,306 $7.03 Million
Q3 2021 Oct 19, 2021	BUY	$282.99 - $369.05 $895,946 - $1.17 Million	3,166 Added 18.65%	20,144 $5.7 Million
Q2 2021 Jul 29, 2021	BUY	$259.0 - $414.71 $372,701 - $596,767	1,439 Added 9.26%	16,978 $5.88 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $3.29 Million - $4.96 Million	13,943 Added 873.62%	15,539 $3.81 Million
Q3 2017 Nov 16, 2017	SELL	$281.15 - $329.69 $28,114 - $32,969	-100 Reduced 5.9%	1,596 $500,000
Q2 2017 Aug 11, 2017	BUY	N/A	1,696	1,696 $491 Million

Others Institutions Holding BIIB

# of Institutions

993

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Icici Prudential Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Icici Prudential Asset Management CO LTD with notifications on news.

Account

Icici Prudential Asset Management CO LTD Biogen Inc. Transaction History